MCLAUGHLIN JOHN PETER
Insider CIK 1277967 · RMTI Director · SGEN Director · LNSR Director · AAVL Director · PDLI President/Chief Exec. Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LNSR LENSAR, Inc. | A Award deriv | 2023-05-25 | 2023-05-30 | 33,175 | — | $0 | 33,175 | SEC↗ |
| LNSR LENSAR, Inc. | A Award | 2023-05-25 | 2023-05-30 | 9,288 | — | $0 | 53,631 | SEC↗ |
| LNSR LENSAR, Inc. | A Award deriv | 2022-05-25 | 2022-05-27 | 15,616 | — | $0 | 15,616 | SEC↗ |
| LNSR LENSAR, Inc. | A Award | 2022-05-25 | 2022-05-27 | 4,285 | — | $0 | 44,343 | SEC↗ |
| RMTI ROCKWELL MEDICAL, INC. | A Award deriv | 2021-06-17 | 2021-06-22 | 72,857 | — | $0 | 72,857 | SEC↗ |
| RMTI ROCKWELL MEDICAL, INC. | A Award | 2021-06-17 | 2021-06-22 | 50,000 | — | $0 | 136,974 | SEC↗ |
| LNSR LENSAR, Inc. | A Award deriv | 2021-05-18 | 2021-05-20 | 20,847 | — | $0 | 20,847 | SEC↗ |
| LNSR LENSAR, Inc. | A Award deriv | 2021-03-12 | 2021-03-16 | 13,445 | — | $0 | 13,445 | SEC↗ |
| LNSR LENSAR, Inc. | A Award deriv | 2021-02-01 | 2021-02-02 | 28,249 | — | $0 | 28,249 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | S Sale | 2020-12-22 | 2020-12-22 | 277,934 | $2.61 | $725.4K | 200,000 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | S Sale | 2020-12-21 | 2020-12-22 | 50,000 | $2.62 | $131.0K | 477,934 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award deriv | 2020-08-19 | 2020-08-24 | 118,671 | $3.63 | $430.8K | 118,671 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2020-08-19 | 2020-08-24 | 25,826 | — | $0 | 527,934 | SEC↗ |
| RMTI ROCKWELL MEDICAL, INC. | A Award deriv | 2020-05-18 | 2020-05-20 | 34,024 | — | $0 | 34,024 | SEC↗ |
| RMTI ROCKWELL MEDICAL, INC. | A Award | 2020-05-18 | 2020-05-20 | 51,800 | — | $0 | 86,974 | SEC↗ |
| RMTI ROCKWELL MEDICAL, INC. | A Award | 2020-01-29 | 2020-01-31 | 12,615 | — | $0 | 35,174 | SEC↗ |
| RMTI ROCKWELL MEDICAL, INC. | A Award deriv | 2019-09-05 | 2019-09-06 | 28,372 | — | $0 | 28,372 | SEC↗ |
| RMTI ROCKWELL MEDICAL, INC. | A Award | 2019-09-05 | 2019-09-06 | 22,559 | — | $0 | 22,559 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award deriv | 2019-06-20 | 2019-07-08 | 126,050 | $3.00 | $378.1K | 126,050 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | D To issuer | 2018-12-31 | 2019-01-09 | 123,449 | — | $0 | 502,108 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | D To issuer | 2018-12-27 | 2018-12-28 | 627,228 | — | $0 | 625,557 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award deriv | 2018-06-08 | 2018-06-12 | 1,922,100 | — | $0 | 1,922,100 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | D To issuer | 2017-12-15 | 2017-12-19 | 151,678 | — | $0 | 1,252,785 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2017-03-04 | 2017-03-07 | 588,235 | $2.04 | $1.20M | 1,404,463 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | D To issuer | 2016-12-13 | 2016-12-15 | 5,168 | — | $0 | 816,228 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2016-05-20 | 2016-05-24 | 9,260 | — | $0 | 9,260 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2016-05-20 | 2016-05-24 | 3,700 | — | $0 | 39,400 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award deriv | 2016-02-12 | 2016-02-17 | 11,905 | — | $0 | 11,905 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award | 2016-02-12 | 2016-02-17 | 8,333 | — | $0 | 10,333 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2016-01-26 | 2016-01-28 | 403,727 | $3.22 | $1.30M | 821,396 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2015-05-15 | 2015-05-19 | 9,260 | — | $0 | 9,260 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2015-05-15 | 2015-05-19 | 3,700 | — | $0 | 35,700 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award deriv | 2015-04-21 | 2015-04-23 | 7,000 | — | $0 | 7,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award | 2015-04-21 | 2015-04-23 | 2,000 | — | $0 | 2,000 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2015-01-28 | 2015-01-30 | 129,201 | $7.62 | $984.5K | 417,669 | SEC↗ |
| AAVL Avalanche Biotechnologies, | C Conversion deriv | 2014-08-05 | 2014-08-07 | 13,280 | — | $0 | 0 | SEC↗ |
| AAVL Avalanche Biotechnologies, | C Conversion deriv | 2014-08-05 | 2014-08-07 | 13,280 | — | $0 | 0 | SEC↗ |
| AAVL Avalanche Biotechnologies, | C Conversion | 2014-08-05 | 2014-08-07 | 13,280 | — | $0 | 13,280 | SEC↗ |
| AAVL Avalanche Biotechnologies, | C Conversion | 2014-08-05 | 2014-08-07 | 13,280 | — | $0 | 13,280 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award deriv | 2014-07-30 | 2014-08-01 | 75,000 | — | $0 | 75,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2014-05-16 | 2014-05-20 | 8,750 | $34.25 | $299.7K | 8,750 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2014-05-16 | 2014-05-20 | 3,500 | — | $0 | 32,000 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2014-04-10 | 2014-04-15 | 119,770 | $8.22 | $984.5K | 288,468 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2013-05-17 | 2013-05-21 | 8,750 | $36.70 | $321.1K | 8,750 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2013-05-17 | 2013-05-21 | 3,500 | — | $0 | 28,500 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2013-01-24 | 2013-01-28 | 29,911 | $6.72 | $201.0K | 168,698 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2012-05-18 | 2012-05-22 | 17,500 | $20.06 | $351.1K | 17,500 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2012-01-18 | 2012-01-20 | 31,955 | $6.29 | $201.0K | 138,787 | SEC↗ |